Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
United Therapeutics
MedTech
United Therapeutics buys Miromatrix in $91M xenotransplant deal
The deal shakes out to a price of $3.25 per share, for what the companies described as about a 170% premium over Miromatrix’s 30-day average value.
Conor Hale
Oct 30, 2023 10:45am
Revivicor sees 61 days' function in kidney+thymus xenotransplant
Sep 25, 2023 9:45am
New Fair Inclusion score rates cancer clinical trial diversity
Jan 5, 2023 9:25am
First pig heart successfully transplanted in human patient
Jan 11, 2022 10:05am
LGBTQ+ progress in biotech lingers in the 'diagnose' stage
Dec 6, 2021 7:00am
NYU surgeons transplant gene-edited pig kidney into a human
Oct 20, 2021 10:15am
